Britannia Life Sciences Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported net income was CAD 5.08 million compared to net loss of CAD 15.46 million a year ago. Basic earnings per share from continuing operations was CAD 0.03 compared to basic loss per share from continuing operations of CAD 0.14 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | +40.00% | +40.00% | -6.67% |
1st Jan change | Capi. | |
---|---|---|
-6.67% | 5.93M | |
+17.10% | 8.44B | |
+7.54% | 7.78B | |
+14.30% | 6.77B | |
-3.66% | 3.81B | |
-7.34% | 3.71B | |
+1.78% | 1.4B | |
-28.57% | 1.09B | |
+18.84% | 1.03B | |
-12.01% | 901M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. Reports Earnings Results for the Full Year Ended March 31, 2023